The 20 Best Metastatic Brain Tumor Doctors Near Me in Monroeville, PA

Rahul J. Kumar, MD, is a radiation oncologist specializing in the treatment of all radiation oncology cases. Dr. Kumar is rated as an Advanced provider by MediFind in the treatment of Metastatic Brain Tumor. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Breast Cancer, and Primitive Neuroectodermal Tumor (PNET). Dr. Kumar is board certified in American Board Of Radiology. Dr. Kumar is currently accepting new patients.

Jan Drappatz, MD, is a neuro-oncologist, an associate professor at the University of Pittsburgh School of Medicine, and the director of the Neuro-oncology program at UPMC. Dr. Drappatz specializes in the treatment of primary and metastatic brain tumors and neurologic complications of cancer. Dr. Drappatz is rated as a Distinguished provider by MediFind in the treatment of Metastatic Brain Tumor. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Gliomatosis Cerebri. Dr. Drappatz is board certified in American Board Of Psychiatry And Neurology. Dr. Drappatz is currently accepting new patients.

Shirley Ong, MD, specializes in hematology oncology and is board-certified in neurology by the American Board of Psychiatry and Neurology. She practices at UPMC Hillman Cancer Center and is affiliated with UPMC Shadyside and UPMC Presbyterian. Dr. Ong received her medical degree from the University of the East Ramon Magsaysay Memorial Medical Center and completed her residency at Saint Louis University School of Medicine, followed by a fellowship at the University of Texas MD Anderson Cancer Center. Dr. Ong is rated as a Distinguished provider by MediFind in the treatment of Metastatic Brain Tumor. She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Brain Tumor. Dr. Ong is board certified in American Board Of Psychiatry And Neurology. Dr. Ong is currently accepting new patients.

Steven Burton, MD, is an associate professor of radiation oncology at the University of Pittsburgh School of Medicine. Dr. Burton holds an interest in stereotactic radiosurgery, lymphoma, lung cancer, pancreas cancer, and spinal metastasis. Dr. Burton is rated as a Distinguished provider by MediFind in the treatment of Metastatic Brain Tumor. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Metastatic Brain Tumor, Pancreaticoduodenectomy, and Gamma Knife Radiosurgery. Dr. Burton is board certified in American Board Of Internal Medicine and American Board Of Radiology. Dr. Burton is currently accepting new patients.

Dr. Lunsford is the Lars Leksell Professor and Distinguished Professor of neurological surgery at the University of Pittsburgh School of Medicine. He is also the director of the Center for Image-Guided Neurosurgery and the Residency Training Program at UPMC. Dr. Lunsford is rated as a Distinguished provider by MediFind in the treatment of Metastatic Brain Tumor. He is also highly rated in 53 other conditions, according to our data. His clinical expertise encompasses Meningioma, Acoustic Neuroma, Schwannoma, Gamma Knife Radiosurgery, and Rhizotomy. Dr. Lunsford is board certified in American Board Of Neurological Surgery. Dr. Lunsford is currently accepting new patients.

Ajay Niranjan, MD, specializes in neurosurgery. He practices at the University of Pittsburgh Physicians, Department of Neurological Surgery and is affiliated with UPMC Presbyterian.  Dr. Niranjan is associate professor of neurological surgery at the University of Pittsburgh School of Medicine. He received his medical degree from King George’s Medical College in Lucknow, India, where he also completed his neurosurgical residency. Dr. Niranjan then completed a fellowship in image-guided neurosurgery at the University of Pittsburgh.A leading expert on stereotactic radiosurgery, Dr. Niranjan has helped develop guidelines for stereotactic radiosurgery for trigeminal neuralgia, pituitary adenomas, arteriovenous malformations, acoustic neuromas, and brain metastases.Dr. Niranjan has co-authored more than 120 articles in journals such as Neurosurgery, Journal of Neurosurgery, and Journal of Neuro-oncology; contributed more than 55 book chapters; and edited two books on stereotactic radiosurgery. Dr. Niranjan is rated as a Distinguished provider by MediFind in the treatment of Metastatic Brain Tumor. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Schwannoma, Brain Tumor, Metastatic Brain Tumor, Gamma Knife Radiosurgery, and Rhizotomy. Dr. Niranjan is currently accepting new patients.

John C. Flickinger, MD, FACR, is a professor of radiation oncology and neurological surgery at the University of Pittsburgh School of Medicine. Dr. Flickinger holds an interest in spine tumors, brain tumors, metastatic diseases, effects of radiation on normal tissue, and the mathematical modeling of radiation response. Dr. Flickinger is rated as a Distinguished provider by MediFind in the treatment of Metastatic Brain Tumor. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Brain Tumor, Metastatic Brain Tumor, Meningioma, Gamma Knife Radiosurgery, and Rhizotomy. Dr. Flickinger is board certified in American Board Of Radiology. Dr. Flickinger is currently accepting new patients.

Dhaval R. Mehta, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center. Dr. Mehta treats all types of cancer and has special interest in hematological disorders and solid tumors, and clinical trials in the community setting. Dr. Mehta is rated as an Experienced provider by MediFind in the treatment of Metastatic Brain Tumor. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Polycythemia Vera, Paget Disease of the Breast, Familial Pancreatic Cancer, and Neuroendocrine Tumor. Dr. Mehta is board certified in American Board Of Internal Medicine , American Board Of Internal Medicine , and American Board Of Internal Medicine. Dr. Mehta is currently accepting new patients.

Nishant Tageja, MD, is a medical oncologist and hematologist. Dr. Tageja specializes in the treatment of solid tumors such as breast cancer, lung cancer, and colon cancer as well as treatment of all benign and malignant blood disorders including lymphoma, leukemia, and myeloma. Dr. Tageja is rated as an Experienced provider by MediFind in the treatment of Metastatic Brain Tumor. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Smoldering Multiple Myeloma, Familial Colorectal Cancer, Breast Cancer, Small Cell Lung Cancer (SCLC), and Bone Marrow Transplant. Dr. Tageja is board certified in American Board Of Internal Medicine , American Board Of Internal Medicine , and American Board Of Internal Medicine. Dr. Tageja is currently accepting new patients.

Thomas Nabhani, MD, specializes in radiation oncology and is board-certified by the American Board of Radiology. He practices at UPMC Hillman Cancer Center and Mountain View Cancer Associates. Dr. Nabhani completed his medical degree at the University of Illinois College of Medicine, residency at Johns Hopkins University School of Medicine and SUNY Downstate Health Sciences University, and fellowship at UCLA Department of Surgery. Dr. Nabhani is rated as an Experienced provider by MediFind in the treatment of Metastatic Brain Tumor. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Prostate Cancer, and Breast Cancer. Dr. Nabhani is board certified in American Board Of Radiology. Dr. Nabhani is currently accepting new patients.

Roby A. Thomas, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center. Dr. Thomas is trained in the management of all cancers and blood disorders with a focus in genitourinary and gastrointestinal malignancies. Dr. Thomas is rated as an Advanced provider by MediFind in the treatment of Metastatic Brain Tumor. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, Gamma Knife Radiosurgery, and Endoscopy. Dr. Thomas is board certified in American Board Of Internal Medicine , American Board Of Internal Medicine , and American Board Of Internal Medicine. Dr. Thomas is currently accepting new patients.

Megan M. Mantica, MD, is an assistant professor of neurology and medicine at the University of Pittsburgh School of Medicine in the division of hematology/oncology. She specializes in the treatment of adult high grade gliomas, central nervous system lymphoma, and neurological complications of cancer treatment. Her translational research interests include womenís neuro-oncology, reproductive neuro-oncology and metastatic brain disease, and high grade gliomas. Dr. Mantica is rated as an Advanced provider by MediFind in the treatment of Metastatic Brain Tumor. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Glioma, Brain Tumor, Glioblastoma, and Astrocytoma. Dr. Mantica is board certified in American Board Of Psychiatry And Neurology. Dr. Mantica is currently accepting new patients.

Daniel P. Petro, MD, is a medical oncologist and hematologist at Hillman Cancer Center. He treats all cancer types, and has a special interest in a multidisciplinary approach to thoracic malignancies. Dr. Petro is also heavily involved in the research of Phase I trials. Dr. Petro is rated as an Advanced provider by MediFind in the treatment of Metastatic Brain Tumor. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, Gamma Knife Radiosurgery, and Awake Craniotomy. Dr. Petro is board certified in American Board Of Internal Medicine. Dr. Petro is currently accepting new patients.

Jaime Mullin, DO, is a medical oncologist at UPMC Hillman Cancer Center. Dr. Mullin is rated as an Advanced provider by MediFind in the treatment of Metastatic Brain Tumor. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Small Cell Lung Cancer (SCLC), Posterior Fossa Tumor, Pleuropulmonary Blastoma, Gamma Knife Radiosurgery, and Gastrostomy. Dr. Mullin is board certified in American Board Of Internal Medicine , American Board Of Internal Medicine , and American Board Of Internal Medicine.

John M. Kirkwood, MD, is a professor of medicine, dermatology, and clinical and translational science at the University of Pittsburgh School of Medicine and the Clinical and Translational Science Institute at the University of Pittsburgh. Dr. Kirkwood directs the Melanoma Center at UPMC Hillman Cancer Center and specializes in melanoma research and the prevention and early detection of melanoma, as well as the treatment of advanced disease and adjuvant therapy of resectable disease. Dr. Kirkwood is rated as an Advanced provider by MediFind in the treatment of Metastatic Brain Tumor. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Melanoma, Melanoma of the Eye, Metastatic Uveal Melanoma, and Uveal Melanoma. Dr. Kirkwood is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Kirkwood is currently accepting new patients.

John K. Waas, DO, is a medical oncologist at UPMC Hillman Cancer Center who practices at Arnold Palmer Medical Oncology at Norwin. Board-certified in medical oncology, Dr. Waas received his medical degree from Philadelphia College of Osteopathic Medicine in Philadelphia. He completed his residency at Lehigh Valley Hospital Center in Allentown, Pa. Dr. Waas is rated as an Advanced provider by MediFind in the treatment of Metastatic Brain Tumor. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Congenital Antithrombin 3 Deficiency, Protein C Deficiency, Hereditary Resistance to Anti-Vitamin K, and Protein S Deficiency. Dr. Waas is board certified in American Board Of Internal Medicine , American Board Of Internal Medicine , and American Board Of Internal Medicine. Dr. Waas is currently accepting new patients.

Serah Choi, MD, PhD, specializes in radiation oncology and is board certified in radiation oncology by the American Board of Radiology. She practices at UPMC Hillman Cancer Center and is affiliated with UPMC Mercy. Dr. Choi completed her medical education at University of Pittsburgh School of Medicine and residency at University of California San Francisco. Dr. Choi is rated as an Advanced provider by MediFind in the treatment of Metastatic Brain Tumor. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, Metastatic Brain Tumor, Glioma, and Gamma Knife Radiosurgery. Dr. Choi is board certified in American Board Of Radiology. Dr. Choi is currently accepting new patients.

Dr. Zinn is assistant professor of neurological surgery at the University of Pittsburgh School of Medicine and associate director of the Adult Neurosurgical Oncology Program. He specializes in neurosurgical oncology.Dr. Zinn received his medical degree from the University of Zurich in Switzerland and received his PhD from the University of Lausanne. He completed his neurosurgery residency at Baylor College of Medicine and MD Anderson Cancer Center. He then completed a fellowship at Dana-Farber Cancer Institute, Harvard Medical School.In addition to his clinical focus in neuro-oncology, Dr. Zinn’s research focuses on patient-centered care for brain and spinal tumors. Utilizing humanoid brain organoid cancer models, Dr. Zinn simulates the patient’s tumor condition in the laboratory and studies the origins of how the tumor forms and how tumors can be treated using tumor genetics precision approaches. Furthermore, Dr. Zinn is developing personalized biologically-adaptable and patient-tailored, virus-based therapies for brain cancer.Pascal Zinn, MD, PhD, specializes in surgical oncology and neurosurgery. He practices at University of Pittsburgh Physicians, Department of Neurological Surgery and is affiliated with UPMC Magee-Womens Hospital, UPMC Presbyterian, and UPMC Shadyside. He completed his residency at Baylor College of Medicine and medical degree at University of Zurich. Dr. Zinn is rated as an Advanced provider by MediFind in the treatment of Metastatic Brain Tumor. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Astrocytoma, Glioblastoma, Glioma, Awake Craniotomy, and Cordotomy. Dr. Zinn is board certified in American Board Of Neurological Surgery. Dr. Zinn is currently accepting new patients.

Costas G. Hadjipanayis, MD, PhD, is a board-certified neurosurgeon who has devoted his entire career to the treatment of brain tumor patients. He completed his neurosurgical residency and graduate PhD training at the University of Pittsburgh with additional neurosurgical oncology training at the University of California, San Francisco. Dr. Hadjipanayis is rated as an Advanced provider by MediFind in the treatment of Metastatic Brain Tumor. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Glioma, Glioblastoma, Brain Tumor, Gamma Knife Radiosurgery, and Awake Craniotomy. Dr. Hadjipanayis is board certified in American Board Of Neurological Surgery. Dr. Hadjipanayis is currently accepting new patients.

Adam M. Brufsky, MD, PhD, FACP, is professor of medicine at the University of Pittsburgh School of Medicine and also serves as the associate division chief for the Division of Hematology/Oncology at the University of Pittsburgh School of Medicine's Department of Medicine. Dr. Brufsky is the medical director of the Magee-Women's Cancer Program, part of the UPMC Hillman Cancer Center, and UPMC Hillman Cancer Center; associate director for clinical investigations at UPMC Hillman Cancer Center; and codirector of the Comprehensive Breast Cancer Center.Dr. Brufsky is board-certified in internal medicine and medical oncology. He earned a medical and doctor of philosophy degrees from the University of Connecticut School of Medicine in Farmington, Conn.; completed a residency at Brigham and Women's Hospital, Harvard Medical School, and a fellowship at Dana-Farber Cancer Institute.Dr. Brufsky is a member of professional organizations, such as American Medical Association, Massachusetts Medical Society, American College of Physicians, American Society of Clinical Oncology, American Association for Cancer Research, Allegheny County Medical Society, Pennsylvania Medical Society, and Pennsylvania Oncologic Society. An active researcher, Dr. Brufsky has numerous abstracts and research articles in leading journals, and is principal investigator on a number of research grants funded by the National Institutes of Health, Susan G. Komen Foundation, and US Army - Breast Cancer Research Program. Dr. Brufsky is rated as an Advanced provider by MediFind in the treatment of Metastatic Brain Tumor. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, Breast Cancer in Men, and Gastrostomy. Dr. Brufsky is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Brufsky is currently accepting new patients.